AdvaTab Advanced ODT technology provides easy ingestion for pediatric, geriatric, and dysphagic patients
- Composed of finely micronized particles rapidly disintegrating into a smooth, viscous suspension
- An easy-to-take dosage solution:
- Masks bitter drug taste
- Rapidly dissolves in the mouth without water
- AdvaTab tablets have been proven bioequivalent to immediate or sustained release formulations
Patented formulations and manufacturing process
- Advatabs® incorporate uniformly dispersed, coated drug particles in a low-moisture, rapidly disintegrating matrix
- Formulated for acceptable taste, a disintegration time <30 seconds
- Suitable for push-through blister packs and multiple-packing configurations
- Up to 500 mg drug-loading capability
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS and Philadelphia, PA facilities, where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.